Recommendations for the Management of Subsolid Pulmonary Nodules Detected at CT: A Statement from the Fleischner Society

References

• 1 MacMahon H, Austin JH, Gamsu G, et al.. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237(2):395–400.
  Google Scholar
• 2 Eisenberg RL, Bankier AA, Boiselle PM. Compliance with Fleischner Society guidelines for management of small lung nodules: a survey of 834 radiologists. Radiology 2010;255(1):218–224.
  Google Scholar
• 3 MacMahon H. Compliance with Fleischner Society guidelines for management of lung nodules: lessons and opportunities. Radiology 2010;255(1):14–15.
  Google Scholar
• 4 Godoy MCB, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009;253(3):606–622.
  Google Scholar
• 5 Kim HK, Choi YS, Kim J, Shim YM, Lee KS, Kim K. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010;5(2):206–210.
  MedlineGoogle Scholar
• 6 Kim HK, Choi YS, Kim K, et al.. Management of ground-glass opacity lesions detected in patients with otherwise operable non–small cell lung cancer. J Thorac Oncol 2009;4(10):1242–1246.
  MedlineGoogle Scholar
• 7 Jeudy J, White CS, Munden RF, Boiselle PM. Management of small (3–5-mm) pulmonary nodules at chest CT: global survey of thoracic radiologists. Radiology 2008;247(3):847–853.
  Google Scholar
• 8 van Klaveren RJ, Oudkerk M, Prokop M, et al.. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361(23):2221–2229.
  MedlineGoogle Scholar
• 9 Goo JM, Park CM, Lee HJ. Ground-glass nodules on chest CT as imaging biomarkers in the management of lung adenocarcinoma. AJR Am J Roentgenol 2011;196(3):533–543.
  MedlineGoogle Scholar
• 10 Prosch H, Strasser G, Oschatz E, Schober E, Schneider B, Mostbeck GH. Management of patients with small pulmonary nodules: a survey of radiologists, pulmonologists, and thoracic surgeons. AJR Am J Roentgenol 2006;187(1):143–148.
  MedlineGoogle Scholar
• 11 Schultz EM, Silvestri GA, Gould MK. Variation in experts’ beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol 2008;3(4):422–426.
  MedlineGoogle Scholar
• 12 Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277–300.
  MedlineGoogle Scholar
• 13 Travis WD, Brambilla E, Noguchi M, et al.. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6(2):244–285.
  MedlineGoogle Scholar
• 14 Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15(1):4–9.
  MedlineGoogle Scholar
• 15 Raj V, Bajaj A, Entwisle JJ. Implications of new (seventh) TNM classification of lung cancer on general radiologists: a pictorial review. Curr Probl Diagn Radiol 2011;40(2):85–93.
  MedlineGoogle Scholar
• 16 National Lung Screening Trial Research TeamAberle DR, Adams AM, et al.. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395–409.
  MedlineGoogle Scholar
• 17 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246(3):697–722.
  Google Scholar
• 18 Austin JH, Müller NL, Friedman PJ, et al.. Glossary of terms for CT of the lungs: recommendations of the nomenclature committee of the Fleischner Society. Radiology 1996;200(2):327–331.
  Google Scholar
• 19 Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007;245(1):267–275.
  Google Scholar
• 20 Kodama K, Higashiyama M, Takami K, et al.. Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. Eur J Cardiothorac Surg 2008;34(5):1068–1074.
  MedlineGoogle Scholar
• 21 Takashima S, Maruyama Y, Hasegawa M, et al.. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol 2003;180(3):817–826.
  MedlineGoogle Scholar
• 22 Yoshida J, Nagai K, Yokose T, et al.. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 2005;129(5):991–996.
  MedlineGoogle Scholar
• 23 Yang ZG, Sone S, Takashima S, et al.. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. AJR Am J Roentgenol 2001;176(6):1399–1407.
  MedlineGoogle Scholar
• 24 Gandara DR, Aberle D, Lau D, et al.. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J Thorac Oncol 2006;1(9 Suppl):S20–S26.
  MedlineGoogle Scholar
• 25 Ikeda N, Maeda J, Yashima K, et al.. A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter. Ann Thorac Surg 2004;78(3):1011–1016.
  MedlineGoogle Scholar
• 26 Sagawa M, Higashi K, Usuda K, et al.. Curative wedge resection for non-invasive bronchioloalveolar carcinoma. Tohoku J Exp Med 2009;217(2):133–137.
  MedlineGoogle Scholar
• 27 Higashiyama M, Kodama K, Yokouchi H, et al.. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg 1999;68(6):2069–2073.
  MedlineGoogle Scholar
• 28 Matsuguma H, Yokoi K, Anraku M, et al.. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002;124(2):278–284.
  MedlineGoogle Scholar
• 29 Yanagawa M, Kuriyama K, Kunitomi Y, et al.. One-dimensional quantitative evaluation of peripheral lung adenocarcinoma with or without ground-glass opacity on thin-section CT images using profile curves. Br J Radiol 2009;82(979):532–540.
  MedlineGoogle Scholar
• 30 Yanagawa M, Tanaka Y, Kusumoto M, et al.. Automated assessment of malignant degree of small peripheral adenocarcinomas using volumetric CT data: correlation with pathologic prognostic factors. Lung Cancer 2010;70(3):286–294.
  MedlineGoogle Scholar
• 31 Ohde Y, Nagai K, Yoshida J, et al.. The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma. Lung Cancer 2003;42(3):303–310.
  MedlineGoogle Scholar
• 32 Travis WD, Brambilla E, Noguchi M, et al.. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification [abstr]. J Thorac Oncol 2009;4(9):S86–S89.
  Google Scholar
• 33 Sica G, Yoshizawa A, Sima CS, et al.. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010;34(8):1155–1162.
  MedlineGoogle Scholar
• 34 Noguchi M, Morikawa A, Kawasaki M, et al.. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995;75(12):2844–2852.
  MedlineGoogle Scholar
• 35 Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Mandrekar JN. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest 2009;136(6):1586–1595.
  MedlineGoogle Scholar
• 36 Guyatt G, Gutterman D, Baumann MH, et al.. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006;129(1):174–181.
  MedlineGoogle Scholar
• 37 Maeshima AM, Tochigi N, Yoshida A, Asamura H, Tsuta K, Tsuda H. Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence. J Thorac Oncol 2010;5(4):466–471.
  MedlineGoogle Scholar
• 38 Min JH, Lee HY, Lee KS, et al.. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer 2010;69(1):123–126.
  MedlineGoogle Scholar
• 39 Yoshida J. Management of the peripheral small ground-glass opacities. Thorac Surg Clin 2007;17(2):191–201, viii.
  MedlineGoogle Scholar
• 40 Hasegawa M, Sone S, Takashima S, et al.. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73(876):1252–1259.
  MedlineGoogle Scholar
• 41 Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102(9): 605–613.
  MedlineGoogle Scholar
• 42 Park CM, Goo JM, Lee HJ, Kim KG, Kang MJ, Shin YH. Persistent pure ground-glass nodules in the lung: interscan variability of semiautomated volume and attenuation measurements. AJR Am J Roentgenol 2010;195(6):W408–W414.
  MedlineGoogle Scholar
• 43 Singh S, Pinsky P, Fineberg NS, et al.. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology 2011;259(1):263–270.
  Google Scholar
• 44 Lin EC. Radiation risk from medical imaging. Mayo Clin Proc 2010;85(12):1142–1146; quiz 1146.
  MedlineGoogle Scholar
• 45 Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ, Im JG. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. RadioGraphics 2007;27(2):391–408.
  Google Scholar
• 46 Kang MJ, Kim MA, Park CM, Lee CH, Goo JM, Lee HJ. Ground-glass nodules found in two patients with malignant melanomas: different growth rate and different histology. Clin Imaging 2010;34(5):396–399.
  MedlineGoogle Scholar
• 47 Park CM, Goo JM, Kim TJ, et al.. Pulmonary nodular ground-glass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions? Chest 2008;133(6):1402–1409.
  MedlineGoogle Scholar
• 48 Kodama K, Higashiyama M, Yokouchi H, et al.. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002;73(2):386–392; discussion 392–393.
  MedlineGoogle Scholar
• 49 Oda S, Awai K, Murao K, et al.. Computer-aided volumetry of pulmonary nodules exhibiting ground-glass opacity at MDCT. AJR Am J Roentgenol 2010;194(2):398–406.
  MedlineGoogle Scholar
• 50 Oda S, Awai K, Liu D, et al.. Ground-glass opacities on thin-section helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia. AJR Am J Roentgenol 2008;190(5):1363–1368.
  MedlineGoogle Scholar
• 51 Godoy MC, Nonaka D, Lowy J, Ko JP. Ground-glass centrilobular nodules on multidetector CT scan: incidental diagnosis in a patient with pneumonia. Chest 2010;138(2):427–433.
  MedlineGoogle Scholar
• 52 Nakata M, Saeki H, Takata I, et al.. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002;121:1464–1467.
  MedlineGoogle Scholar
• 53 Hiramatsu M, Inagaki T, Inagaki T, et al.. Pulmonary ground-glass opacity (GGO) lesions: large size and a history of lung cancer are risk factors for growth. J Thorac Oncol 2008;3(11):1245–1250.
  MedlineGoogle Scholar
• 54 Sawada S, Komori E, Nogami N, Segawa Y, Shinkai T, Yamashita M. Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination. Lung Cancer 2009;65(2):176–179.
  MedlineGoogle Scholar
• 55 Henschke CI, Shaham D, Yankelevitz DF, Altorki NK. CT screening for lung cancer: past and ongoing studies. Semin Thorac Cardiovasc Surg 2005;17(2):99–106.
  MedlineGoogle Scholar
• 56 Swensen SJ, Jett JR, Hartman TE, et al.. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235(1):259–265.
  Google Scholar
• 57 Khokhar S, Mironov S, Seshan VE, Stover DE, Khirbat R, Feinstein MB. Antibiotic use in the management of pulmonary nodules. Chest 2010;137(2):369–375.
  MedlineGoogle Scholar
• 58 Funama Y, Awai K, Liu D, et al.. Detection of nodules showing ground-glass opacity in the lungs at low-dose multidetector computed tomography: phantom and clinical study. J Comput Assist Tomogr 2009;33(1):49–53.
  MedlineGoogle Scholar
• 59 Hein PA, Romano VC, Rogalla P, et al.. Linear and volume measurements of pulmonary nodules at different CT dose levels: intrascan and interscan analysis. Rofo 2009;181(1):24–31.
  MedlineGoogle Scholar
• 60 Cloran FJ, Banks KP, Song WS, Kim Y, Bradley YC. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity. Lung Cancer 2010;68(1):66–71.
  MedlineGoogle Scholar
• 61 Raz DJ, Odisho AY, Franc BL, Jablons DM. Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 2006;132(5):1189–1195.
  MedlineGoogle Scholar
• 62 Heyneman LE, Patz EF. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 2002;38(3):261–266.
  MedlineGoogle Scholar
• 63 Higashi K, Ueda Y, Yagishita M, et al.. FDG PET measurement of the proliferative potential of non–small cell lung cancer. J Nucl Med 2000;41(1):85–92.
  MedlineGoogle Scholar
• 64 Lee HY, Lee KS, Han J, et al.. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer 2009;65(2):170–175.
  MedlineGoogle Scholar
• 65 Maeda R, Isowa N, Onuma H, et al.. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size. Interact Cardiovasc Thorac Surg 2009;9(1):70–73.
  MedlineGoogle Scholar
• 66 Tsunezuka Y, Shimizu Y, Tanaka N, Takayanagi T, Kawano M. Positron emission tomography in relation to Noguchi’s classification for diagnosis of peripheral non–small-cell lung cancer 2 cm or less in size. World J Surg 2007;31(2):314–317.
  MedlineGoogle Scholar
• 67 Chun EJ, Lee HJ, Kang WJ, et al.. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: the feasibility of integrated (18)F-FDG PET/CT. Lung Cancer 2009;65(2):180–186.
  MedlineGoogle Scholar
• 68 Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002;29(9):1166–1173.
  MedlineGoogle Scholar
• 69 Franks TJ, Galvin JR, Jett JR, Naidich DP, Boiselle PM. Expert opinion: role of percutaneous biopsy of part-solid nodules in the IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma. J Thorac Imaging 2011;26(3):189.
  MedlineGoogle Scholar
• 70 Shimizu K, Ikeda N, Tsuboi M, Hirano T, Kato H. Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT. Lung Cancer 2006;51(2):173–179.
  MedlineGoogle Scholar
• 71 Wagnetz U, Menezes RJ, Boerner S, et al.. CT screening for lung cancer: implication of lung biopsy recommendations. AJR Am J Roentgenol 2012;198(2):351–358.
  MedlineGoogle Scholar
• 72 Kim TJ, Lee JH, Lee CT, et al.. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 2008;190(1):234–239.
  MedlineGoogle Scholar
• 73 Lee HJ, Goo JM, Lee CH, Yoo CG, Kim YT, Im JG. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radiol 2007;8(1):22–31.
  MedlineGoogle Scholar
• 74 Henschke CI, Yankelevitz DF, Mirtcheva R, et al.. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178(5):1053–1057.
  MedlineGoogle Scholar
• 75 Mun M, Kohno T. Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. J Thorac Cardiovasc Surg 2007;134(4):877–882.
  MedlineGoogle Scholar
• 76 Ikeda K, Awai K, Mori T, Kawanaka K, Yamashita Y, Nomori H. Differential diagnosis of ground-glass opacity nodules: CT number analysis by three-dimensional computerized quantification. Chest 2007;132(3):984–990.
  MedlineGoogle Scholar
• 77 Lee SM, Park CM, Goo JM, et al.. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology 2010;255(1):242–251.
  Google Scholar
• 78 Jennings SG, Winer-Muram HT, Tann M, Ying J, Dowdeswell I. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology 2006;241(2):554–563.
  Google Scholar
• 79 Nakata M, Sawada S, Yamashita M, et al.. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non–small cell lung cancer. J Thorac Cardiovasc Surg 2005;129(6):1226–1231.
  MedlineGoogle Scholar
• 80 Aoki T, Tomoda Y, Watanabe H, et al.. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220(3):803–809.
  Google Scholar
• 81 Kim EA, Johkoh T, Lee KS, et al.. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. AJR Am J Roentgenol 2001;177(6):1417–1422.
  MedlineGoogle Scholar
• 82 Kobayashi N, Toyooka S, Ichimura K, et al.. Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung. J Thorac Oncol 2008;3(7):704–710.
  MedlineGoogle Scholar
• 83 Vazquez M, Carter D, Brambilla E, et al.. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009;64(2):148–154.
  MedlineGoogle Scholar
• 84 de Hoop B, Gietema H, van de Vorst S, Murphy K, van Klaveren RJ, Prokop M. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology 2010;255(1):199–206.
  Google Scholar
• 85 Jennings SG, Winer-Muram HT, Tarver RD, Farber MO. Lung tumor growth: assessment with CT—comparison of diameter and cross-sectional area with volume measurements. Radiology 2004;231(3):866–871.
  Google Scholar
• 86 Lindell RM, Hartman TE, Swensen SJ, et al.. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;242(2):555–562.
  Google Scholar
• 87 Marchianò A, Calabrò E, Civelli E, et al.. Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology 2009;251(3):919–925.
  Google Scholar
• 88 Okada M, Nishio W, Sakamoto T, Uchino K, Tsubota N. Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Ann Thorac Surg 2003;76(6):1828–1832; discussion 1832.
  MedlineGoogle Scholar
• 89 Sumikawa H, Johkoh T, Nagareda T, et al.. Pulmonary adenocarcinomas with ground-glass attenuation on thin-section CT: quantification by three-dimensional image analyzing method. Eur J Radiol 2008;65(1):104–111.
  MedlineGoogle Scholar
• 90 Zhang L, Yankelevitz DF, Henschke CI, Jirapatnakul AC, Reeves AP, Carter D. Zone of transition: a potential source of error in tumor volume estimation. Radiology 2010;256(2):633–639.
  Google Scholar
• 91 Zhao B, James LP, Moskowitz CS, et al.. Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non–small cell lung cancer. Radiology 2009;252(1):263–272.
  Google Scholar
• 92 Kakinuma R, Kodama K, Yamada K, et al.. Performance evaluation of 4 measuring methods of ground-glass opacities for predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer: a multicenter study. J Comput Assist Tomogr 2008;32(5):792–798.
  MedlineGoogle Scholar
• 93 Ko JP, Berman EJ, Kaur M, et al.. Pulmonary nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry. Radiology 2012;262(2):662–671.
  Google Scholar
• 94 Casali C, Cucca M, Rossi G, et al.. The variation of prognostic significance of maximum standardized uptake value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected non–small cell lung carcinoma. Lung Cancer 2010;69(2):187–193.
  MedlineGoogle Scholar
• 95 Higashi K, Sakuma T, Ito K, et al.. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma. Eur J Nucl Med Mol Imaging 2009;36(3):373–381.
  MedlineGoogle Scholar
• 96 Lee HY, Han J, Lee KS, et al.. Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings. Lung Cancer 2009;66(3):379–385.
  MedlineGoogle Scholar
• 97 Nair VS, Barnett PG, Ananth L, Gould MK; Veterans Affairs Solitary Nodule Accuracy Project Cooperative Studies Group. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non–small cell lung cancer. Chest 2010;137(5):1150–1156.
  MedlineGoogle Scholar
• 98 Okada M, Tauchi S, Iwanaga K, et al.. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg 2007;133(6):1448–1454.
  MedlineGoogle Scholar
• 99 Pastorino U, Landoni C, Marchianò A, et al.. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers. J Thorac Oncol 2009;4(11):1352–1356.
  MedlineGoogle Scholar
• 100 Watanabe K, Nomori H, Ohtsuka T, et al.. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol 2006;36(7):403–409.
  MedlineGoogle Scholar
• 101 Kohno T, Fujimori S, Kishi K, Fujii T. Safe and effective minimally invasive approaches for small ground glass opacity. Ann Thorac Surg 2010;89(6):S2114–S2117.
  MedlineGoogle Scholar
• 102 Koike T, Togashi K, Shirato T, et al.. Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg 2009;88(4):1106–1111.
  MedlineGoogle Scholar
• 103 Asamura H. Minimally invasive approach to early, peripheral adenocarcinoma with ground-glass opacity appearance. Ann Thorac Surg 2008;85(2):S701–S704.
  MedlineGoogle Scholar
• 104 Girard N, Deshpande C, Lau C, et al.. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 2009;33(12):1752–1764.
  MedlineGoogle Scholar
• 105 Nakata M, Sawada S, Yamashita M, et al.. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg 2004;78(4):1194–1199.
  MedlineGoogle Scholar
• 106 Zwirewich CV, Miller RR, Müller NL. Multicentric adenocarcinoma of the lung: CT-pathologic correlation. Radiology 1990;176(1):185–190.
  Google Scholar
• 107 Finley DJ, Yoshizawa A, Travis WD, et al.. Predictors of outcomes after surgical treatment of synchronous primary lung cancers. J Thorac Oncol 2010;5(2):197–205.
  MedlineGoogle Scholar
• 108 Battafarano RJ, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg 2002;74(4):988–993; discussion 993–994.
  MedlineGoogle Scholar
• 109 Roberts PF, Straznicka M, Lara PN, et al.. Resection of multifocal non–small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg 2003;126(5):1597–1602.
  MedlineGoogle Scholar
• 110 Glynn C, Zakowski MF, Ginsberg MS. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features? J Thorac Oncol 2010;5(3):344–348.
  MedlineGoogle Scholar
• 111 Yoshizawa A, Motoi N, Riely GJ, et al.. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24(5):653–664.
  MedlineGoogle Scholar
• 112 Tsutani Y, Miyata Y, Nakayama H, et al.. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. J Thorac Cardiovasc Surg 2012;143(3):607–612.
  MedlineGoogle Scholar
• 113 Carter D, Vazquez M, Flieder DB, et al.. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 2007;56(2):193–199.
  MedlineGoogle Scholar